Abstract
Increased longevity has been achieved by genetic and environmental manipulations in model organisms, from nematodes to mammals. Genes that can extend life span when altered are referred to as “gerontogenes.” The last several years have seen a dramatic increase in the number of identified gerontogenes (approximately seventy-four). The vast majority of these genes have been identified in the nematode, Caenorhabditis elegans. These genes include age-1 (a phosphatidylinositol 3-OH kinase gene) and daf-2 (an insulin-like receptor gene), as well as genes mediating behavior, metabolism, reproduction and sensory perception. age-1 and daf-2 play a role in a hormonal signaling cascade similar to the mammalian insulin / IGF-1 pathways. The age-1 / daf-2 signal functions to shorten life span and repress the positive regulators of life span, daf-16 and old-1. Similarly, studies of Dwarf mice indicate that the growth hormone-IGF-1 axis may play a role in regulating longevity. Signals from certain tissues, such as sensory neurons and gonads, also regulate life span in C. elegans. The gonadal signal is dependent on the daf-9 cytochrome P450 gene and the daf-12 steroid receptor gene, implicating roles of steroid hormones in longevity. Moreover, increased resistance to intrinsic and environmental stresses [heat, UV, and reactive oxygen species (ROS)] has been shown to be intimately related to increased longevity in a variety of species. ROS scavengers, including superoxide dismutase (SOD) and SOD mimetics, can extend life span in the fruit fly Drosophila melanogaster and in C. elegans, respectively. We suggest that environmental and intrinsic stresses, depending on the evolutionary niche occupied by the species, are key factors that control life span and aging. In summary, cellular signals regulate systemic mechanisms that play a role in stress resistance and also affect longevity.
Current Genomics
Title: Regulation of Life Span in Model Organisms
Volume: 4 Issue: 1
Author(s): Shin Murakami and Thomas E. Johnson
Affiliation:
Abstract: Increased longevity has been achieved by genetic and environmental manipulations in model organisms, from nematodes to mammals. Genes that can extend life span when altered are referred to as “gerontogenes.” The last several years have seen a dramatic increase in the number of identified gerontogenes (approximately seventy-four). The vast majority of these genes have been identified in the nematode, Caenorhabditis elegans. These genes include age-1 (a phosphatidylinositol 3-OH kinase gene) and daf-2 (an insulin-like receptor gene), as well as genes mediating behavior, metabolism, reproduction and sensory perception. age-1 and daf-2 play a role in a hormonal signaling cascade similar to the mammalian insulin / IGF-1 pathways. The age-1 / daf-2 signal functions to shorten life span and repress the positive regulators of life span, daf-16 and old-1. Similarly, studies of Dwarf mice indicate that the growth hormone-IGF-1 axis may play a role in regulating longevity. Signals from certain tissues, such as sensory neurons and gonads, also regulate life span in C. elegans. The gonadal signal is dependent on the daf-9 cytochrome P450 gene and the daf-12 steroid receptor gene, implicating roles of steroid hormones in longevity. Moreover, increased resistance to intrinsic and environmental stresses [heat, UV, and reactive oxygen species (ROS)] has been shown to be intimately related to increased longevity in a variety of species. ROS scavengers, including superoxide dismutase (SOD) and SOD mimetics, can extend life span in the fruit fly Drosophila melanogaster and in C. elegans, respectively. We suggest that environmental and intrinsic stresses, depending on the evolutionary niche occupied by the species, are key factors that control life span and aging. In summary, cellular signals regulate systemic mechanisms that play a role in stress resistance and also affect longevity.
Export Options
About this article
Cite this article as:
Murakami Shin and Johnson E. Thomas, Regulation of Life Span in Model Organisms, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350137
DOI https://dx.doi.org/10.2174/1389202033350137 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Different Methods for Cell Viability and Proliferation Assay: Essential Tools in
Pharmaceutical Studies
Anti-Cancer Agents in Medicinal Chemistry A Comprehensive Review on Anti-obesity Potential of Medicinal Plants and their Bioactive Compounds
Current Traditional Medicine Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
Current Alzheimer Research Probiotics as an Adjuvant Therapy in Major Depressive Disorder
Current Neuropharmacology Glycaemic Control: A Balancing Act or A Different Approach?
Current Diabetes Reviews Preparation of Chitosan/Alginate-ellagic Acid Sustained-release Microspheres and their Inhibition of Preadipocyte Adipogenic Differentiation
Current Pharmaceutical Biotechnology Issues of Quantitative Metabolic Brain Imaging with Small Animal PET in Mice
Current Medical Imaging Antibiotic-Induced Liver Toxicity: Mechanisms, Clinical Features and Causality Assessment
Current Drug Safety Non-dipping Status in Arterial Hypertension: An Overview
Current Vascular Pharmacology Heart Failure in Diabetes Mellitus: An Updated Review
Current Pharmaceutical Design Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study
Current HIV Research Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects
Current Medicinal Chemistry Heart Failure in North America
Current Cardiology Reviews Ovalbumin Induced Allergic Rhinitis and Development of Prediabetes to Rats: Possible Role of Th2 Cytokines
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Basal-Like Breast Cancers
Current Drug Targets Editorial [Hot Topic: Vasoactive Intestinal Peptide (VIP): Historic Perspective and Future Potential]
Endocrine, Metabolic & Immune Disorders - Drug Targets State of the Art in African Trypanosome Drug Discovery
Current Topics in Medicinal Chemistry Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patient with Hodgkin's Lymphoma History from North of Iran
Infectious Disorders - Drug Targets Acknowledgements to Reviewers:
Current Diabetes Reviews Dyslipidemia as a Risk Factor for Ischemic Stroke
Current Topics in Medicinal Chemistry